"Bitte beachten Sie, dass derzeit keine Patientenbesuche möglich sind."

During the past decade, medius KLINIK KIRCHHEIM conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "medius KLINIK KIRCHHEIM" are "Giant Cell Arteritis" (1 trials) and "Sjogren's Syndrome" (1 trials). Many other conditions were trialed in "medius KLINIK KIRCHHEIM" in a lesser frequency.

Most popular intervention types in "medius KLINIK KIRCHHEIM" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Guselkumab" (1 trials), "Nipocalimab" (1 trials) and "Standard of Care Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "medius KLINIK KIRCHHEIM" are 2 trials for "All" genders.

Currently, there are NaN active trials in "medius KLINIK KIRCHHEIM". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in medius KLINIK KIRCHHEIM, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in medius KLINIK KIRCHHEIM, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".